文献速递妇科产科母胎医学

遗传性肿瘤管理中的争议问题

Controversies in Hereditary Cancer Management.
PubMed 文献 · Obstet Gynecol · 2021-01-01

本文综述遗传性肿瘤风险管理中的争议,强调应由遗传咨询师、外科医生、女性健康或绝经专家、心理师及妇产科医生等组成多学科团队进行个体化管理。文中讨论高危患者识别、乳腺癌与卵巢癌的普遍检测、特殊人群检测、遗传检测结果的简化沟通及直接面向消费者检测的细节,并涉及妊娠与哺乳期乳腺癌筛查的关注点。文章还为选择降低风险输卵管卵巢切除术或乳房切除术的女性提供实用管理与咨询框架,深入探讨手术时机、生育力保存、更年期症状管理与手术技术等问题。

要点

  • 遗传性肿瘤风险管理宜采用多学科团队模式,涵盖遗传咨询、外科、女性健康或绝经专科、心理及基层或妇产科医生。
  • 需关注高危患者识别、乳腺癌与卵巢癌的普遍检测、特殊人群检测及直接面向消费者检测的细节。
  • 为选择降低风险输卵管卵巢切除术或乳房切除术的女性提供手术时机、生育力保存、更年期症状管理与手术技术的咨询框架。

核心结论

  • 遗传性肿瘤管理应个体化、多学科协作,涵盖识别、检测、筛查预防、手术决策及长期心理支持。

主要发现

  • 文章描述了高危患者识别、乳腺癌与卵巢癌普遍检测及特殊人群检测中的问题。
  • 文章介绍了理解与沟通遗传检测结果的简化方法及直接面向消费者检测的细节。
  • 文章强调了妊娠与哺乳期乳腺癌筛查的关注点。

临床怎么用

  • 临床应为选择降低风险输卵管卵巢切除术或乳房切除术的女性提供实用管理与咨询框架。
  • 临床应就手术时机、生育力保存、更年期症状管理及手术技术与患者深入讨论。
  • 对选择延迟双侧输卵管卵巢切除术的女性应回顾替代选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Personalized management of patients at risk ideally should involve a multidisciplinary team of not only genetic counselors and surgeons, but also women's health or menopause specialists, knowledgeable psychologists, and primary care providers or obstetrician-gynecologists aware of the risks and fears "previvors" (survivors of a predisposition to cancer who have not had the disease) face as well as the issues that are common postoperatively. Identification of patients at risk for hereditary cancer, understanding of current genetic testing modalities and potential results, knowledge about screening and prevention including timing of surveillance, preventive medication and risk-reducing surgeries, understanding limitations and comorbidities associated with these risk management strategies and long-term psychological support are all important in hereditary cancer management. We describe issues surrounding the identification of the high-risk patient, universal testing in breast and ovarian cancer, and testing in special populations. We describe a simplified approach to understanding and communicating genetic testing results and nuances of testing including direct-to-consumer testing. We highlight concerns surrounding breast cancer screening during pregnancy and lactation. A framework for practical management and counseling of women who opt for risk-reducing salpingo-oophorectomy or risk-reducing mastectomy or both is provided. We provide an in-depth discussion of questions that arise in relation to timing of surgery, fertility preservation, management of menopausal symptoms, and surgical technique. Alternative choices in women who choose to delay bilateral salpingo-oophorectomy are reviewed. Finally, the psychosocial effects of carrying a genetic mutation and the issues that women face when undergoing to risk-reducing surgery including adjustment, sexuality issues, and cosmesis are addressed.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. AlHilli MM, Pederson HJ. Controversies in Hereditary Cancer Management. Obstet Gynecol. 2021. PMID: 33831930. doi:10.1097/AOG.0000000000004364

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。